StockVS

NASDAQ · USD

SAB Biotherapeutics, Inc. (SABSW) Stock Analysis

SAB Biotherapeutics, Inc. (SABSW) is a stock listed on NASDAQ and quoted in US Dollar.

SABSW

$0.02

+$0.00 (+0.43%)

Sep 4, 2026 · Market close

This is a derivative instrument — a warrant on SAB Biotherapeutics, Inc. (SABS) common stock.

Issuer fundamentals are shown on the issuer page, not here.

View SABS →

Price History

Hover for the daily close. The dotted line marks the period open.

SABSW Key Statistics

As of Sep 4, 2026
Trading
Open
$0.05
Previous Close
$0.02
Volume
611
BetaHow much the share price moves relative to the wider market. 1.0 moves in line with it; above 1.0 swings more, below 1.0 less.
0.54

Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.

SABSW Stock Return by Calendar Year

Calendar-year returns computed from daily closing prices. Partial years are shown muted and marked with an asterisk.

YearReturn
2026 (partial year)−4.45%
2025 (partial year)+0.00%

As of September 4, 2026.

Recent News

News provided by third-party sources. Not financial advice.

About SAB Biotherapeutics, Inc.

SAB Biotherapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of human polyclonal immunotherapeutic antibodies to address immune system disorders and infectious diseases in the United States. Its lead product candidate is SAB-142, a potentially disease-modifying and redosable immunotherapy in clinical development for the treatment of autoimmune type 1 diabetes in Phase 2b clinical trials. The company was founded in 2014 and is headquartered in Miami Beach, Florida.

Visit website →